新利18客服电话|18新利投注平台
Skip to content Skip to search Skip to footer John T. Milliken Department of Medicine Division of Dermatology Open Menu Back Close Menu Search for: Search Close Search About UsAbout Us History Notable Contributions Patient CarePatient Care Coronavirus (COVID-19) Response Preparing for your Visit Uploading Pictures Request an Appointment Patient EducationPatient Education Mohs Micrographic Surgery Specialties and SitesSpecialties and Sites Aesthetic Services Dermatologic Surgery General Dermatology Pediatric Dermatology ResearchResearch Publications Funding Sources Research Labs Clinical Trials News Giving EducationEducation Residency ProgramResidency Program How to Apply Updates on 2023-2024 Application Cycle Physician Scientist Training Program (PSTP) Clinical Curriculum and Schedule Clinical and Didactic Education Didactic Schedule Call Schedule Current Residents Graduates Resident Life Diversity &＃038; Inclusion Wellness Special Programs Fellowship ProgramsFellowship Programs Dermatopathology Fellowship Micrographic Surgery and Dermatologic Oncology Fellowship Pediatric Dermatology Fellowship Medical Student Education Grand RoundsGrand Rounds Grand Rounds Submission Form Patient Instruction Sheet PeoplePeople Faculty Fellows Residents Contact Us Open Search Clinical Trials The Dermatology Clinical Trials Unit is nationally recognized for developing and participating in clinical therapeutic trials. Clinical trials allow our patients to be exposed to experimental therapeutics. The trials unit is experienced in all areas of dermatologic clinical research from pre-Phase I to Phase IV. We are currently participating in a broad range of clinical trials of novel therapeutics for inflammatory and neoplastic skin disorders. The trials unit draws on the Division of Dermatology&＃8217;s vast clinical experience. Dermatology Clinical Trials Unit Phone: (314) 273-3897 Email: [email protected] EPIC: WU IM DERM CLINICAL TRIALS POOL Currently Enrolling Trials ATOPIC DERMATITIS The Purpose of This Study is to Evaluate the Effects of Ruxolitinib Cream on Adults With Atopic Dermatitis Experiencing Sleep Disturbance. (MORPHEUS) ClinicalTrials.gov Identifier: NCT05696392 CUTANEOUS T-CELL LYMPHOMA Real World Observational Study of Poteligeo in Adult Patients with Mycosis Fungoides and Sezary Syndrome (PROSPER) ClinicalTrials.gov Identifier: NCT05455931 HIDRADENITIS SUPPURATIVA A Phase 3 Study to Evaluate the Efficacy and Safety of Povorcitinib (oral JAK-i) in Participants with Moderate to Severe Hidradenitis Suppurativa (HS) (STOP-HS2) ClinicalTrials.gov Identifier: NCT05620836 A Phase 2, randomized, double-blind, placebo-controlled, parallel group, proof-of-concept study assessing the efficacy and safety of amlitelimab (SQ; anti-OX40L) in adult participants with moderate to severe Hidradenitis Suppurativa ClinicalTrials.gov Identifier: NCT06118099 A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Efficacy and Safety of Upadacitinib (oral JAK-i) in Adult and Adolescent Subjects with Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy ClinicalTrials.gov Identifier: NCT05889182 A Phase 2 Multicenter, Open-Label Sub Study to Evaluate the Safety and Efficacy of Lutikizumab (SQ; anti-IL-1) in Adult Subjects with Moderate to Severe Hidradenitis Suppurativa ClinicalTrials.gov Identifier: NCT05139602 A Phase 2b, Double-Blind, Placebo-Controlled Study to Evaluate Eltrekibart (SQ; anti CXC 1/2) in Adult Participants with Moderate to Severe Hidradenitis Suppurativa ClinicalTrials.govIdentifier:NCT06046729 SKIN CANCER Phase IIa, Single-arm, Open-label, Clinical Trial of calcipotriene plus 5-fluorouracil Immunotherapy for Skin Cancer Prevention in Organ Transplant Recipients ClinicalTrials.govIdentifier:NCT0569903 SUPPORTIVE ONCODERMATOLOGY Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors (CLEER) ClinicalTrials.gov Identifier: NCT05639933 Research Publications Funding Sources Research Labs Clinical Trials Division of DermatologyJohn T. Milliken Department of Internal MedicineAppointments: 314-273-DERM(3376)More contact information Resources Diversity & Inclusion Grand Rounds Didactic Schedule Clinical Schedules Call Schedule Follow Us Twitter Instagram ©2024 Washington University in St. Louis
